Precigen (PGEN) Return on Capital Employed Growth (3y) (2016 - 2026)
Precigen (PGEN) Return on Capital Employed Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | -3,782.00 |
| 10 | Precigen | 1.95 Bn | 1.95 Bn | 20.69 Mn | -3,222.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,222.00 |
| Dec 31, 2025 | -4,001.00 |
| Sep 30, 2025 | -7,140.00 |
| Jun 30, 2025 | -8,295.00 |
| Mar 31, 2025 | -8,936.00 |
| Dec 31, 2024 | -11,926.00 |
| Sep 30, 2024 | -21,858.00 |
| Jun 30, 2024 | -14,624.00 |
| Mar 31, 2024 | -6,206.00 |
| Dec 31, 2023 | -3,689.00 |
| Sep 30, 2023 | -1,478.00 |
| Jun 30, 2023 | 313.00 |
| Mar 31, 2023 | -297.00 |
| Dec 31, 2022 | -670.00 |
| Sep 30, 2022 | 2,592.00 |
| Jun 30, 2022 | 3,173.00 |
| Mar 31, 2022 | 3,319.00 |
| Dec 31, 2021 | 2,513.00 |
| Sep 30, 2021 | -791.00 |
| Jun 30, 2021 | -807.00 |